Eupraxia Pharmaceuticals Files 6-K, Submits Form 40-F
Ticker: EPRX · Form: 6-K · Filed: Jun 3, 2025 · CIK: 1581178
Sentiment: neutral
Topics: reporting, annual-report, foreign-private-issuer
TL;DR
Eupraxia Pharma (EPRX) filed its 6-K, submitting its 40-F annual report. All good.
AI Summary
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on June 3, 2025, for the month of June 2025. The company, headquartered in Victoria, British Columbia, Canada, is a foreign private issuer. This filing indicates they are submitting their annual report under Form 40-F.
Why It Matters
This filing signals that Eupraxia Pharmaceuticals Inc. is meeting its reporting obligations as a foreign private issuer by submitting its annual report, which is crucial for investors to stay informed about the company's performance and compliance.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer to submit their annual report, not indicating any new material events or financial distress.
Key Players & Entities
- EUPRAXIA PHARMACEUTICALS INC. (company) — Filer of the 6-K report
- 001-41923 (company) — SEC File Number
- 201-2067 Cadboro Bay Road Victoria, British Columbia, Canada V8R 5G4 (company) — Registrant's principal executive office address
- Form 40-F (company) — Annual report submission type
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is filed by Eupraxia Pharmaceuticals Inc. to report information that it has made or is required to make public pursuant to the laws of Canada, or to file or make public a document that it has filed or is required to file with any stock exchange on which its securities are traded. Specifically, this filing indicates they are submitting their annual report under Form 40-F.
What is the filing date of this report?
The filing date of this report is June 3, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at 201-2067 Cadboro Bay Road, Victoria, British Columbia, Canada V8R 5G4.
Does Eupraxia Pharmaceuticals Inc. file its annual reports under Form 20-F or Form 40-F?
Eupraxia Pharmaceuticals Inc. indicates it files its annual reports under cover of Form 40-F.
What is the SEC file number for Eupraxia Pharmaceuticals Inc.?
The SEC file number for Eupraxia Pharmaceuticals Inc. is 001-41923.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 3, 2025 regarding EUPRAXIA PHARMACEUTICALS INC. (EPRX).